Rainbow Childrens Medicare Ltd Q1 FY27 Results Analysis: Revenue Surges 33%, Margin Compresses 71 bps
Rainbow Childrens Medicare Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 469.99 Cr (+33.17% YoY) and PAT growth of +13.22% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 30, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 469.99 Cr (+33.17% YoY) |
| PAT (Q1) | Rs. 60.57 Cr (+13.22% YoY) |
| EBITDA margin | 28.65% (-71 bps YoY) |
| EPS (Q1) | Rs. 5.97 (+13.28% YoY) |
| Market cap | Rs. 15,444.22 Cr |
| CMP | Rs. 1,520.60 |
Quarter Snapshot
Consolidated revenue grew 33% YoY, powered by acquisitions that added Rs.41 Cr in revenue. However, EBITDA margin compressed 71 bps YoY and PAT-owners growth lagged revenue significantly, with standalone PAT nearly flat. New hospital expansions in Mumbai and Nellore provide future catalysts but near-term margin pressure persists.
Key Investment Insights
Key Positives
- Consolidated revenue grew 33.17% YoY to Rs.469.99 Cr, with organic standalone growth of 22.64%.
- Subsidiary revenue contribution from acquisitions jumped from Rs.18.18 Cr to Rs.59.44 Cr, reflecting successful integration.
- EBITDA grew 29.94% YoY to Rs.134.65 Cr.
- EPS grew 13.28% YoY to Rs.5.97.
Risk Factors
- EBITDA margin compressed 71 bps YoY to 28.65% and 248 bps QoQ, indicating cost pressure.
- PAT-owners growth (13.22%) significantly lagged revenue growth (33.17%), reflecting margin erosion.
- Standalone PAT grew only 1.91% YoY, showing organic profitability weakness.
- Professional fees to doctors grew faster than revenue QoQ (+9.89% vs +2.19%), pressuring margins.
- No FY27 forward guidance provided, reducing visibility on future trajectory.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.